1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6048001A3DD44633785257F73005C9BA7
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/048001A3DD44633785257F73005C9BA7!OpenDocument
18
19OpenDocument
2098.80.143.34
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




» Products & Services » » Medical Affairs » Thought Leader Services

Document Excerpt: Internal Thought Leader Management: Responsibilities and Resource Allocation

DB Image

ID: MD-505


Features:

13 Info Graphics

23 Data Graphics

250 Metrics

6 Narratives


Pages/Slides: 4


Published: Pre-2019


Delivery Format: Online PDF Document


 

License Options:


Download FREE Excerpt

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER

To download this excerpt, click
"Download Free Excerpt".

To return to the study abstract to purchase the full study
- click here

This excerpt includes research findings and metrics from document #5404 "Internal Thought Leader Management: Responsibilities and Resource Allocation".

Industries Profiled:
Biopharmaceutical; Biotech; Pharmaceutical; Manufacturing; Consumer Products; Diagnostic; Medical Device; Chemical; Health Care; Clinical Research; Laboratories


Companies Profiled:
Alkermes; Allergan; Baxalta; Bayer; Celldex Therapeutics; CSL Behring; Genentech; Genzyme; GW Pharmaceuticals; Indivior; Jazz Pharmaceuticals; Mesoblast; Neurocrine Biosciences; Norgine; Novo Nordisk; Perrigo Company; Pfizer; ProStrakan; Sanofi; Santen; Shire; Stallergenes; Sunovion; Teva Pharmaceutical Industries Ltd; Theravance; Tris Pharma; UCB Pharma

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.